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Abstract
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim This is, to our knowledge, the most
comprehensive analysis to date based on generative topographic mapping (GTM) of fragment-
like chemical space (40 million molecules with no more than 17 heavy atoms, both from the
theoretically enumerated GDB-17 and real-world PubChem/ChEMBL databases). The challenge
was to prove that a robust map of fragment-like chemical space can actually be built, in spite of
a limited (≪105) maximal  number of  compounds (“frame set”)  usable for  fitting the GTM
manifold. An evolutionary map building strategy has been updated with a “coverage check”
step, which discards manifolds failing to accommodate compounds outside the frame set. The
evolved map has a good propensity to separate actives from inactives for more than 20 external
structure–activity sets. It was proven to properly accommodate the entire collection of 40 m
compounds.  Next,  it  served as  a  library  comparison  tool  to  highlight  biases  of  real-world
molecules (PubChem and ChEMBL) versus the universe of all possible species represented by
FDB-17, a fragment-like subset of GDB-17 containing 10 million molecules. Specific patterns,
proper to some libraries and absent from others (diversity holes), were highlighted.
http://dx.doi.org/10.1002/cmdc.201700561
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